Clinical Trial Update: A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating saxagliptin added to sulfonylurea therapy in adults with type 2 diabetes who have inadequate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2009-09-25